What Does Regulus Therapeutics Do?

Total employees56
HeadquartersSan Diego
Founded2007

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus is leveraging its pioneering understanding of microRNA biology and chemistry to develop a pipeline of microRNA therapeutics designed to address a broad range_of_diseases with high unmet medical need, including autosomal dominant polycystic kidney disease (ADPKD) and other chronic kidney and rare diseases. Their approach aims to modulate fundamental disease pathways, offering potential for transformative treatments.

Where Is Regulus Therapeutics's Headquarters?

HQ Function

The headquarters serves as the central hub for research and development, clinical operations, corporate administration, and strategic leadership.

Notable Features:

The facility includes modern laboratory spaces equipped for RNA therapeutic research and office environments designed for collaboration.

Work Culture:

The work culture emphasizes innovation, scientific rigor, collaboration, and a patient-focused approach to drug development. Employees are often driven by the potential to make significant impacts in treating serious diseases.

HQ Significance:

Its location in a prominent biotech cluster allows for access to talent, research institutions, and potential collaborators, fostering innovation.

Values Reflected in HQ: The headquarters' focus on cutting-edge research facilities reflects the company's commitment to scientific excellence and innovation in the field of microRNA therapeutics.

Location:

While Regulus Therapeutics is primarily based in the United States, its clinical development programs may involve trial sites and collaborations in multiple countries. The company engages with the global scientific and medical community to advance its research and therapeutic candidates.

Street Address:

10614 Science Center Drive, Suite 225

City:

San Diego

State/Province:

CA

Country:

USA

Where Else Does Regulus Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Regulus Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Regulus Therapeutics? Meet the Executive Team

As of April 2025, Regulus Therapeutics' leadership includes:

Joseph P. Hagan - President and Chief Executive Officer
Cris Calsada, Ph.D. - Chief Scientific Officer
Rekha Garg, M.D. - Chief Medical Officer
Claire Padgett, Ph.D. - Chief Business Officer
Jennifer K. Laux - Chief Operating Officer and General Counsel

Who's Investing in Regulus Therapeutics?

Regulus Therapeutics has been backed by several prominent investors over the years, including:

New Enterprise Associates (NEA)
Orbimed
Vivo Capital
Federated Hermes Kaufmann Funds
Venrock Healthcare Capital Partners
Biogen
AstraZeneca (historical)

What Leadership Changes Has Regulus Therapeutics Seen Recently?

Hire2
Exits0

Regulus Therapeutics has seen key appointments in its executive team over the past year, strengthening its leadership in medical and business operations. No major C-suite departures have been publicly announced in the immediate last 12 months, following earlier transitions.

New Appointments:

Rekha Garg, M.D., Dr. Rekha Garg appointed as Chief Medical Officer to oversee clinical development strategies and execution.
Claire Padgett, Ph.D., Dr. Claire Padgett joined as Chief Business Officer, focusing on strategic partnerships and corporate growth.

What Technology (Tech Stack) Is Used byRegulus Therapeutics?

Discover the tools Regulus Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Regulus Therapeutics Email Formats and Examples

Regulus Therapeutics commonly uses the email format of the first initial followed by the last name.

[first_initial][last]@regulusrx.com

Format

jdoe@regulusrx.com

Example

85%

Success rate

What's the Latest News About Regulus Therapeutics?

GlobeNewswire • May 9, 2024

Regulus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Regulus Therapeutics announced its financial results for Q1 2024, highlighting progress in its RGLS8429 program for ADPKD, including enrollment completion for the third cohort of its Phase 1b MAD clinical trial and positive topline safety and PK/PD data....more

GlobeNewswire • April 2, 2024

Regulus Therapeutics Announces Positive Topline Safety and Pharmacokinetic/Pharmacodynamic Data from Third Cohort of its Phase 1b MAD Clinical Trial of RGLS8429 in Patients with ADPKD

The company reported favorable safety, tolerability, and pharmacokinetic data from the third cohort of its Phase 1b multiple-ascending dose (MAD) trial of RGLS8429. Changes in biomarkers, including polycystins, were observed, supporting the mechanism of action....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Regulus Therapeutics, are just a search away.